SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ARDSLEY ADVISORY PARTNERS LP (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol MARRONE BIO INNOVATIONS INC [ MBII ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner Officer (give title below) X Other (specify below) See Footnote 1.
	3. Date of Earliest Transaction (Month/Day/Year) 06/11/2021
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* ARDSLEY ADVISORY PARTNERS LP (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Ardsley Advisory Partners GP LLC (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Ardsley Partners I GP LLC (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* HEMPLEMAN PHILIP J (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Ardsley Partners Renewable Energy Fund, L.P. (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Ardsley Partners Fund II, L.P. (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Ardsley Partners Advanced Healthcare Fund, L.P. (Last) (First) (Middle) 262 HARBOR DRIVE, 4TH FLOOR (Street) STAMFORD CT 06902 (City) (State) (Zip)

Explanation of Responses:

Remarks:

Footnote 1. This Form 4 is being filed by Ardsley Advisory Partners LP (the "Advisor") on behalf of itself and Ardsley Advisory Partners GP LLC (the "Advisor General Partner"), Ardsley Partners I GP LLC (the "General Partner"), Ardsley Partners Renewable Energy Fund, L.P. (the "Renewable Energy Fund"), Ardsley Partners Advanced Healthcare Fund, L.P. (the "Advanced Healthcare Fund"), Ardsley Partners Fund II, L.P. (the "Fund II"), and Philip J. Hempleman ("Hempleman" and, together with the Advisor, the Advisor General Partner, the General Partner, the Renewable Energy Fund, the Advanced Healthcare Fund, and the Fund II, the "Reporting Persons"). The Advisor General Partner serves as general partner to the Advisor. The General Partner serves as general partner to the Renewable Energy Fund, the Advanced Healthcare Fund, and the Fund II. Hempleman services as managing member to the Advisor, the Advisor General Partner, and the General Partner. *This is a voluntary exit report. As the result of a recent share issuance by the Issuer, the Reporting Persons have less than a 10% ownership interest in the securities of the Issuer and are no longer subject to Section 16 in connection with their transactions in the Issuer's securities. Therefore, the Reporting Persons will no longer file any such transactions in Issuer's securities on Form 4 or Form 5.

	/s/ Steve Napoli, Partner	06/11/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.